heptyl-p-tolyl ether | 57792-41-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: heptyl-p-tolyl ether
• 英文别名: 4-Heptyloxy-toluol；1-p-Tolyloxy-heptan；Heptyl-p-tolyl-aether；n-Heptyl-p-tolyl-aether；1-(Heptyloxy)-4-methylbenzene；1-heptoxy-4-methylbenzene
• CAS: 57792-41-3
• 化学式: C₁₄H₂₂O
• mdl: MFCD01026474
• 分子量: 206.328
• InChiKey: TVCIREPLTFSOSC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.3
• 重原子数：
  15
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.571
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  heptyl-p-tolyl ether 生成 (2-chloromethyl-4-methyl-phenyl)-heptyl ether
  参考文献：
  名称：

  1-benzylpiperidine compounds

  摘要：

  公开号：

  US02589205A1
• 作为产物：
  描述：

  对甲酚 、 1-碘庚烷 在 氢氧化钾 作用下， 生成 heptyl-p-tolyl ether
  参考文献：
  名称：

  Pinette, Justus Liebigs Annalen der Chemie, 1888, vol. 243, p. 32,40

  摘要：

  DOI：

文献信息

• Antibacterial agent and therapeutic agent for Johne's disease containing the same
  申请人：Takahashi Yoshiaki

  公开号：US20090209744A1

  公开（公告）日：2009-08-20

  An antibacterial agent having high antibacterial activity against Mycobacterium avium subsp. paratuberculosis is provided. Specifically, the antibacterial agent of the present invention having high antibacterial activity against Mycobacterium avium subsp. paratuberculosis is a caprazamycin derivative represented, for example, by the following general formula (II): wherein Me is a methyl group; and R 1 is a straight or substantially straight chain alkyl group having 5 to 21 carbon atoms, a straight or substantially straight chain alkenyl group having 5 to 21 carbon atoms, a cycloalkyl group having 5 to 12 carbon atoms, or a phenyl group substituted at the para-position with a straight chain alkyl group having 1 to 14 carbon atoms, a straight chain alkoxy group having 1 to 9 carbon atoms or a cycloalkyl group having 5 to 12 carbon atoms.

  提供了一种对鲁氏分枝杆菌亚种鲁氏分枝杆菌具有高抗菌活性的抗菌剂。具体来说，本发明的抗菌剂对鲁氏分枝杆菌亚种鲁氏分枝杆菌具有高抗菌活性，例如由以下通用公式（II）表示的卡普拉霉素衍生物：其中Me是一个甲基基团；而R1是一个由5至21个碳原子组成的直链或几乎直链烷基基团，由5至21个碳原子组成的直链或几乎直链烯基基团，由5至12个碳原子组成的环烷基基团，或者在对位上用具有1至14个碳原子的直链烷基基团、具有1至9个碳原子的直链烷氧基基团或由5至12个碳原子组成的环烷基基团取代的苯基团。
• MODIFIED GLYCOLIPIDS AND METHODS OF MAKING AND USING THE SAME
  申请人：Porcelli Steven A.

  公开号：US20140227296A1

  公开（公告）日：2014-08-14

  The invention is directed to compositions and methods related to proteins that are physically associated with ceramide-like glycolipids for use as activators of NKT cells. The compositions and methods of the present invention are useful for the prevention and treatment of diseases.

  这项发明涉及与类鞘氨醇糖脂物理相关的蛋白质的组合物和方法，用作NKT细胞的激活剂。本发明的组合物和方法对预防和治疗疾病是有用的。
• [EN] A PROCESS FOR THE PREPARATION OF UV ABSORBERS<br/>[FR] PROCÉDÉ DE PRÉPARATION D'ABSORBEURS UV
  申请人：BASF SE

  公开号：WO2020144094A1

  公开（公告）日：2020-07-16

  The presently claimed invention relates to a novel, highly efficient and general process for the preparation of UV absorbers.

  目前所声称的发明涉及一种新颖、高效和通用的紫外线吸收剂制备过程。
• [EN] A PROCESS FOR THE PREPARATION OF TRIAZINE INTERMEDIATES AND A PROCESS FOR THE PREPARATION OF UV ABSORBERS THEREOF<br/>[FR] PROCÉDÉ DE PRÉPARATION D'INTERMÉDIAIRES DE TRIAZINE ET PROCÉDÉ DE PRÉPARATION D'ABSORBEURS UV ASSOCIÉS
  申请人：BASF SE

  公开号：WO2020144093A1

  公开（公告）日：2020-07-16

  The presently claimed invention relates to a novel, highly efficient and general process for the preparation of the triazine intermediates and their use in the preparation of UV absorbers.

  目前所声称的发明涉及一种新颖、高效和通用的三嗪中间体制备过程及其在制备紫外线吸收剂中的应用。
• Intermediates for imidazonaphthyridines
  申请人：Gerster F. John

  公开号：US20080091010A1

  公开（公告）日：2008-04-17

  Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are disclosed.

  Imidazonaphthyridine和tetrahydroimidazonaphthyridine化合物能够诱导细胞因子如干扰素和肿瘤坏死因子的生物合成。这些化合物具有抗病毒和抗肿瘤的特性。本文披露了制备这些化合物及其中间体的方法。